Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT07409376 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT07409376
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 16 and 75 years.
  • People who have been diagnosed with Crohn's disease and have a narrowing (stricture) in the small bowel — either confirmed by imaging scans or found during a camera examination of the bowel (enteroscopy).
  • People whose Crohn's disease has not responded well enough to standard medicines and treatment approaches.
  • People whose bowel narrowing is less than 5 cm in length.
  • People who have signed a consent form agreeing to take part in the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have significant bowel wall thickening with high-level blood flow detected on ultrasound, or who have complications such as a hole in the bowel (perforation), an abnormal tunnel between body parts (fistula), a deep ulcer, an inflamed mass, or a pocket of infection (abscess).
  • People found to have a deep ulcer within the narrowed section of bowel during a camera examination, which may go into the deeper layers of the bowel wall.
  • People who have narrowings in the food pipe (esophagus), stomach, or the first part of the small intestine (duodenum).
  • People who have narrowings in the large bowel (colon or rectum) or at the valve connecting the small and large bowel (ileocecal valve).
  • People whose small bowel narrowing is complicated by a pocket of infection (abscess), an abnormal tunnel (fistula), or a severe bend in the bowel.
  • People who have three or more small bowel narrowings, or a narrowing that is 5 cm or longer.
  • People whose narrowing was previously treated with a stent, stretching (dilation), or cutting (incision), but who did not have at least one full year free of symptoms after that treatment.
  • People who are pregnant or breastfeeding.
  • People who are not able to safely undergo an internal camera procedure (endoscopy).
  • People with serious blood clotting problems, specifically a platelet count below 70,000/μL or an INR above 1.5 (confirm with trial site if these terms are unfamiliar).
  • People who have advanced cancer or serious disease affecting another major organ.
  • People where cancer in a localised area of the bowel is suspected.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yan Chen, PhD, Second Affiliated Hospital of Zhejiang University School of Medicine

Phone: +86-19857128950

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
31 December 2027

Primary endpoints

Proportion of patients not requiring additional therapeutic interventions at 1-year follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov